Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.

Park YG, Zhao X, Lesueur F, Lowy DR, Lancaster M, Pharoah P, Qian X, Hunter KW.

Nat Genet. 2005 Oct;37(10):1055-62. Epub 2005 Sep 4.

2.
3.

The search for low-penetrance cancer susceptibility alleles.

Houlston RS, Peto J.

Oncogene. 2004 Aug 23;23(38):6471-6. Review.

PMID:
15322517
4.

Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion.

Platet N, Cathiard AM, Gleizes M, Garcia M.

Crit Rev Oncol Hematol. 2004 Jul;51(1):55-67. Review.

PMID:
15207254
5.

The curability of breast cancer and the treatment of advanced disease.

Guarneri V, Conte PF.

Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S149-61. Epub 2004 Apr 24. Review.

PMID:
15107948
6.

Cancer statistics, 2004.

Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ; American Cancer Society.

CA Cancer J Clin. 2004 Jan-Feb;54(1):8-29. Review.

7.

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.

Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, B├ęgin LR, Offit K, Foulkes WD.

Breast Cancer Res. 2004;6(1):R8-R17. Epub 2003 Oct 24.

8.

Goals and objectives in the management of metastatic breast cancer.

Chung CT, Carlson RW.

Oncologist. 2003;8(6):514-20. Review.

9.

Myeloproliferative stem cell disorders by deregulated Rap1 activation in SPA-1-deficient mice.

Ishida D, Kometani K, Yang H, Kakugawa K, Masuda K, Iwai K, Suzuki M, Itohara S, Nakahata T, Hiai H, Kawamoto H, Hattori M, Minato N.

Cancer Cell. 2003 Jul;4(1):55-65.

10.

A bad rap: Rap1 signaling and oncogenesis.

Largaespada DA.

Cancer Cell. 2003 Jul;4(1):3-4.

11.

Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human.

Ewart-Toland A, Briassouli P, de Koning JP, Mao JH, Yuan J, Chan F, MacCarthy-Morrogh L, Ponder BA, Nagase H, Burn J, Ball S, Almeida M, Linardopoulos S, Balmain A.

Nat Genet. 2003 Aug;34(4):403-12.

PMID:
12881723
12.

Rap1 translates chemokine signals to integrin activation, cell polarization, and motility across vascular endothelium under flow.

Shimonaka M, Katagiri K, Nakayama T, Fujita N, Tsuruo T, Yoshie O, Kinashi T.

J Cell Biol. 2003 Apr 28;161(2):417-27. Epub 2003 Apr 21.

13.

DOCK4, a GTPase activator, is disrupted during tumorigenesis.

Yajnik V, Paulding C, Sordella R, McClatchey AI, Saito M, Wahrer DC, Reynolds P, Bell DW, Lake R, van den Heuvel S, Settleman J, Haber DA.

Cell. 2003 Mar 7;112(5):673-84.

14.

AF-6 controls integrin-mediated cell adhesion by regulating Rap1 activation through the specific recruitment of Rap1GTP and SPA-1.

Su L, Hattori M, Moriyama M, Murata N, Harazaki M, Kaibuchi K, Minato N.

J Biol Chem. 2003 Apr 25;278(17):15232-8. Epub 2003 Feb 15.

15.

Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes.

Park YG, Clifford R, Buetow KH, Hunter KW.

Genome Res. 2003 Jan;13(1):118-21.

16.

The GTPase Rap1 regulates phorbol 12-myristate 13-acetate-stimulated but not ligand-induced beta 1 integrin-dependent leukocyte adhesion.

Liu L, Schwartz BR, Tupper J, Lin N, Winn RK, Harlan JM.

J Biol Chem. 2002 Oct 25;277(43):40893-900. Epub 2002 Jun 28.

17.

Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals.

Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG.

Hum Hered. 2002;53(2):79-91.

PMID:
12037407
18.

Effect of germ-line genetic variation on breast cancer survival in a population-based study.

Goode EL, Dunning AM, Kuschel B, Healey CS, Day NE, Ponder BA, Easton DF, Pharoah PP.

Cancer Res. 2002 Jun 1;62(11):3052-7.

19.

The contribution of inherited factors to the clinicopathological features and behavior of breast cancer.

Foulkes WD, Rosenblatt J, Chappuis PO.

J Mammary Gland Biol Neoplasia. 2001 Oct;6(4):453-65. Review.

PMID:
12013534
20.

Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1.

Hunter KW, Broman KW, Voyer TL, Lukes L, Cozma D, Debies MT, Rouse J, Welch DR.

Cancer Res. 2001 Dec 15;61(24):8866-72.

Supplemental Content

Support Center